All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Jennifer Romano, MD, MS

Wilson Szeto, MD
Disclosure(s): Abbott: Speaker (Ongoing); Abbott, Artivion, Atricure, Medtronic, Edwards, Terumo Aortic: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

1. J. Maxwell Chamberlain Paper for General Thoracic Surgery: Assessing Lung Cancer Screening Eligibility Among Lung Cancer Patients in the Boston Lung Cancer Study: An Analysis of 6,239 Lung Cancer Cases
   Alexandra Potter, BS
    
2. Discussant for the J. Maxwell Chamberlain Memorial Paper in General Thoracic Surgery
   Cherie Erkmen, MD
   Disclosure(s): AstraZeneca; BMS; Merck; Roche/Genentech: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Pfizer, USA: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
    
3. J. Maxwell Chamberlain Paper for Perioperative and Critical Care: Insurance-Based Disparities in the Incidence of Cardiac Allograft Vasculopathy Following Heart Transplantation Are Mediated By Follow-Up Care at High Volume Centers
   Sarah Sakowitz, MS, MPH
    
4. Discussant for the J. Maxwell Chamberlain Memorial Paper in Perioperative and Critical Care Surgery
   Ashish Shah, MD
    
5. James S. Tweddell Memorial Paper for Congenital Heart Surgery: Volume-Outcome Relationship of Norwood Procedures: Insights from the National Pediatric Cardiology Quality Improvement Collaborative Database
   Reilly Hobbs, MD, MBS
    
6. Discussant for the James S. Tweddell Memorial Paper in Congenital Surgery
   Christopher E. Mascio, MD
    
7. J. Maxwell Chamberlain Paper for Adult Cardiac Surgery: Valve-in-Valve Transcatheter Aortic Valve Replacement vs. Redo Surgical Aortic Valve Replacement for Degenerated Bioprosthetic Valves in Medicare Patients
   Jake Awtry, MD, MA
    
8. Discussant for the J. Maxwell Chamberlain Memorial Paper in Adult Cardiac Surgery
   Vinod H. Thourani, MD
   Disclosure(s): Abbott Vascular: Consultant (Ongoing); AtriCure Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic Cardiovascular: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
    
9. Late Breaking: Anatomic Lung Resection Is Associated with Improved Survival Compared with Wedge Resection for Stage IA Non-Small Cell Lung Cancer
   Christopher W. Seder, MD
    
10. Discussant
    John D. Mitchell, MD
    Disclosure(s): DaVinci Intuitive Surgical: Advisory Board (Ongoing), Consultant (Ongoing)
     
11. Late Breaking: Bioprosthetic vs. Mechanical Aortic Valve Replacement in Patients 40-75 Years
    Michael E. Bowdish, MD, MS
    Disclosure(s): Renibus Therapeutics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
12. Discussant
    Joseph A. Dearani, MD